Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
159.85
+3.74 (2.40%)
At close: Jul 28, 2026, 4:00 PM EDT
160.26
+0.41 (0.26%)
After-hours: Jul 28, 2026, 7:34 PM EDT
Novartis AG Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 56,693 | 56,674 | 51,722 | 46,660 | 43,461 | 43,974 | |
Revenue Growth | 2.73% | 9.57% | 10.85% | 7.36% | -1.17% | -11.87% |
Cost of Revenue | 14,319 | 13,699 | 12,827 | 12,472 | 11,582 | 11,735 |
Gross Profit | 42,374 | 42,975 | 38,895 | 34,188 | 31,879 | 32,239 |
Selling, General & Admin | 13,129 | 13,248 | 12,566 | 12,517 | 12,193 | 12,827 |
Research & Development | 11,694 | 11,200 | 10,022 | 11,371 | 9,172 | 8,641 |
Other Operating Expenses | 449 | 883 | 1,763 | 531 | 2,568 | 715 |
Total Operating Expenses | 25,272 | 25,331 | 24,351 | 24,419 | 23,933 | 22,183 |
Operating Income | 17,102 | 17,644 | 14,544 | 9,769 | 7,946 | 10,056 |
Interest Income | -11 | -12 | -38 | -13 | -11 | 15,337 |
Interest Expense | -1,390 | -1,144 | -1,006 | -855 | -800 | -787 |
Other Non-Operating Income (Expense) | -179 | -136 | 140 | 222 | 42 | -76 |
Total Non-Operating Income (Expense) | -1,580 | -1,292 | -904 | -646 | -769 | 14,474 |
Pretax Income | 15,522 | 16,352 | 13,640 | 9,123 | 7,177 | 24,530 |
Provision for Income Taxes | 2,775 | 2,385 | 1,701 | 551 | 1,128 | 1,625 |
Net Income | 12,747 | 13,967 | 11,939 | 8,572 | 6,049 | 22,905 |
Minority Interest in Earnings | -10 | -17 | -2 | 4 | 0 | -3 |
Earnings From Discontinued Operations | - | - | - | 6,282 | 906 | 1,113 |
Net Income to Common | 12,757 | 13,984 | 11,941 | 14,850 | 6,955 | 24,021 |
Net Income Growth | -6.57% | 17.11% | -19.59% | 113.52% | -71.05% | 197.58% |
Shares Outstanding (Basic) | 1,913 | 1,939 | 2,018 | 2,077 | 2,181 | 2,243 |
Shares Outstanding (Diluted) | 1,925 | 1,955 | 2,035 | 2,092 | 2,197 | 2,260 |
Shares Change | -3.40% | -3.93% | -2.73% | -4.78% | -2.79% | -1.57% |
EPS (Basic) | 6.66 | 7.21 | 5.92 | 7.15 | 3.19 | 10.71 |
EPS (Diluted) | 6.63 | 7.15 | 5.87 | 7.10 | 3.17 | 10.63 |
EPS Growth | -3.35% | 21.81% | -17.32% | 123.97% | -70.18% | 201.99% |
Free Cash Flow | 16,763 | 17,596 | 16,253 | 13,398 | 13,320 | 14,005 |
Free Cash Flow Growth | -13.25% | 8.26% | 21.31% | 0.59% | -4.89% | 13.17% |
Free Cash Flow Per Share | 8.71 | 9.00 | 7.99 | 6.40 | 6.06 | 6.20 |
Dividends Per Share | 4.666 | 4.666 | 3.862 | 3.919 | 3.461 | 3.401 |
Dividend Growth | 20.81% | 20.81% | -1.44% | 13.24% | 1.77% | 0.29% |
Gross Margin | 74.74% | 75.83% | 75.20% | 73.27% | 73.35% | 73.31% |
Operating Margin | 30.17% | 31.13% | 28.12% | 20.94% | 18.28% | 22.87% |
Profit Margin | 22.48% | 24.64% | 23.08% | 18.37% | 13.92% | 52.09% |
FCF Margin | 29.57% | 31.05% | 31.42% | 28.71% | 30.65% | 31.85% |
EBITDA | 22,544 | 22,919 | 20,658 | 18,152 | 14,911 | 15,615 |
EBITDA Margin | 39.77% | 40.44% | 39.94% | 38.90% | 34.31% | 35.51% |
EBIT | 17,102 | 17,644 | 14,544 | 9,769 | 7,946 | 10,056 |
EBIT Margin | 30.17% | 31.13% | 28.12% | 20.94% | 18.28% | 22.87% |
Effective Tax Rate | 17.88% | 14.59% | 12.47% | 6.04% | 15.72% | 6.62% |